Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
656 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00516412 | Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma | completed | Phase 2 | 35 | Swiss Cancer InstituteOTHER | 3 | Sep 29, 2015 | clinicaltrials |
| NCT00324779 | Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia | completed | Phase 2 | 79 | University Hospital ErlangenOTHER | 2 | Sep 25, 2015 | clinicaltrials |
| NCT01073839 | Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma. | completed | Phase 1 / Phase 2 | 33 | University of ZurichOTHER | 1 | Sep 18, 2015 | clinicaltrials |
| NCT00144807 | ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma | completed | Phase 2 | 128 | Lymphoma Study AssociationOTHER | 3 | Sep 2, 2015 | clinicaltrials |
| NCT01904565 | Hyperthermia and Proton Therapy in Unresectable Soft Tissue Sarcoma(HYPROSAR) | unknown | Phase 1 / Phase 2 | 26 | Kantonsspital AarauOTHER | 1 | Sep 2, 2015 | clinicaltrials |
| NCT02528526 | Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm(OXY1A) | unknown | Phase 1 / Phase 2 | 69 | University of ZurichOTHER | 1 | Aug 19, 2015 | clinicaltrials |
| NCT00978211 | DOTA-TOC in Metastasized Neuroendocrine Tumors | completed | Phase 2 | 1,499 | University Hospital, Basel, SwitzerlandOTHER | 1 | Aug 7, 2015 | clinicaltrials |
| NCT00533078 | Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies(LUNCH1) | completed | Phase 2 | 14 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT00431912 | A Study of APO866 for the Treatment of Cutaneous T-cell Lymphoma | completed | Phase 2 | 25 | Valerio TherapeuticsINDUSTRY | 4 | Jul 8, 2015 | clinicaltrials |
| NCT01009801 | Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer | terminated | Phase 1 / Phase 2 | 27 | Swiss Cancer InstituteOTHER | 1 | Jul 7, 2015 | clinicaltrials |
| NCT01775267 | ALLPS VERSUS PVO Randomized Controlled Trial(ALPPS) | terminated | Phase 2 | 7 | University of ZurichOTHER | 3 | Jun 9, 2015 | clinicaltrials |
| NCT01775280 | Response of Hepatic Tumors to Radioembolization(RESRAD) | withdrawn | Phase 2 | 0 | University of ZurichOTHER | 1 | Jun 9, 2015 | clinicaltrials |
| NCT00796757 | A Study of Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC). | completed | Phase 2 | 146 | Hoffmann-La RocheINDUSTRY | 12 | May 27, 2015 | clinicaltrials |
| NCT00210314 | Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma | completed | Phase 2 | 79 | International Extranodal Lymphoma Study Group (IELSG)OTHER | 1 | Mar 30, 2015 | clinicaltrials |
| NCT00210392 | VELCADE in MALT Lymphoma Pretreated With More Than One Prior Systemic Therapy | terminated | Phase 2 | 12 | International Extranodal Lymphoma Study Group (IELSG)OTHER | 1 | Mar 30, 2015 | clinicaltrials |
| NCT00826579 | Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer | completed | Phase 1 / Phase 2 | 192 | University Hospital, Basel, SwitzerlandOTHER | 1 | Mar 12, 2015 | clinicaltrials |
| NCT00044525 | Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients | completed | Phase 2 | 82 | BayerINDUSTRY | 7 | Dec 23, 2014 | clinicaltrials |
| NCT01666431 | Single-center Investigator Initiated Pilot Study Investigating the Tumor Response of Squamous Cell Carcinoma Lesions in Patients Under Lapatinib Treatment | terminated | Phase 2 | 10 | University of ZurichOTHER | 1 | Dec 3, 2014 | clinicaltrials |
| NCT00555919 | ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer | completed | Phase 2 | 68 | BayerINDUSTRY | 10 | Oct 10, 2014 | clinicaltrials |
| NCT00576758 | GAUSS: A Study of Obinutuzumab (RO5072759) in Patients With Indolent Non-Hodgkin's Lymphoma | completed | Phase 2 | 175 | Hoffmann-La RocheINDUSTRY | 17 | Aug 19, 2014 | clinicaltrials |
| NCT00941460 | Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma(DIRECTOR) | completed | Phase 2 | 105 | Prof. Dr. Wolfgang WickOTHER | 3 | Aug 15, 2014 | clinicaltrials |
| NCT00338130 | Randomised Study to Compare the Efficacy of AZD6244 vs TMZ | completed | Phase 2 | 239 | AstraZenecaINDUSTRY | 10 | Aug 13, 2014 | clinicaltrials |
| NCT00021242 | Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia | completed | Phase 2 | 12 | Children's Oncology GroupNETWORK | 7 | Aug 8, 2014 | clinicaltrials |
| NCT01189253 | Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma | terminated | Phase 2 / Phase 3 | 133 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Aug 8, 2014 | clinicaltrials |
| NCT00002941 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma | completed | Phase 2 | 69 | Children's Oncology GroupNETWORK | 7 | Aug 1, 2014 | clinicaltrials |
| NCT00003234 | Vinorelbine in Treating Children With Recurrent or Refractory Cancers | completed | Phase 2 | 50 | Children's Oncology GroupNETWORK | 7 | Jul 28, 2014 | clinicaltrials |
| NCT00003783 | Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia | completed | Phase 2 | 36 | Children's Oncology GroupNETWORK | 5 | Jul 28, 2014 | clinicaltrials |
| NCT00002804 | Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma | completed | Phase 2 | 43 | Children's Oncology GroupNETWORK | 3 | Jul 25, 2014 | clinicaltrials |
| NCT00003178 | Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia | completed | Phase 2 | 120 | Children's Oncology GroupNETWORK | 7 | Jul 25, 2014 | clinicaltrials |
| NCT00003573 | Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma | completed | Phase 2 | 53 | Children's Oncology GroupNETWORK | 5 | Jul 25, 2014 | clinicaltrials |
| NCT00003671 | Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia | completed | Phase 2 | 59 | Children's Oncology GroupNETWORK | 5 | Jul 25, 2014 | clinicaltrials |
| NCT00002594 | Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors | completed | Phase 2 | 31 | Children's Oncology GroupNETWORK | 6 | Jul 24, 2014 | clinicaltrials |
| NCT00002621 | Interferon Alfa in Treating Children With HIV-Related Cancer | completed | Phase 2 | 8 | Children's Oncology GroupNETWORK | 4 | Jul 24, 2014 | clinicaltrials |
| NCT00394693 | Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma | completed | Phase 2 | 13 | TransgeneINDUSTRY | 3 | Jul 16, 2014 | clinicaltrials |
| NCT00705016 | Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)(ADVANTAGE) | completed | Phase 1 / Phase 2 | 184 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 9 | Apr 30, 2014 | clinicaltrials |
| NCT00814619 | Capecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal Cancer | completed | Phase 2 | 68 | Swiss Cancer InstituteOTHER | 2 | Apr 30, 2014 | clinicaltrials |
| NCT01220375 | PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With Myeloma(PAV) | completed | Phase 2 | 44 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Apr 17, 2014 | clinicaltrials |
| NCT01055522 | Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma | terminated | Phase 2 | 102 | Philogen S.p.A.INDUSTRY | 4 | Feb 25, 2014 | clinicaltrials |
| NCT00028795 | Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma | completed | Phase 2 | 170 | Children's Oncology GroupNETWORK | 7 | Feb 21, 2014 | clinicaltrials |
| NCT00006462 | Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia | completed | Phase 2 | 32 | Children's Oncology GroupNETWORK | 7 | Feb 20, 2014 | clinicaltrials |
| NCT00070174 | Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy | completed | Phase 2 | 350 | Children's Oncology GroupNETWORK | 5 | Feb 20, 2014 | clinicaltrials |
| NCT00002756 | Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia | completed | Phase 2 | 221 | Children's Oncology GroupNETWORK | 4 | Feb 14, 2014 | clinicaltrials |
| NCT00003955 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma | completed | Phase 2 | 77 | Children's Oncology GroupNETWORK | 7 | Feb 14, 2014 | clinicaltrials |
| NCT00002688 | Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | unknown | Phase 2 | 25 | University Medical Center GroningenOTHER | 3 | Dec 19, 2013 | clinicaltrials |
| NCT00107471 | Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma | terminated | Phase 1 / Phase 2 | 7 | Children's Oncology GroupNETWORK | 4 | Dec 10, 2013 | clinicaltrials |
| NCT01010295 | A Clinico-Pathological Study to Investigate the Possible Infective Causes of Non-Hodgkin Lymphoma of the Ocular Adnexae(IELSG27) | completed | Phase 2 | 54 | International Extranodal Lymphoma Study Group (IELSG)OTHER | 4 | Nov 25, 2013 | clinicaltrials |
| NCT01164267 | Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL) | completed | Phase 2 | 30 | International Extranodal Lymphoma Study Group (IELSG)OTHER | 3 | Nov 25, 2013 | clinicaltrials |
| NCT01944709 | Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Patients With Inoperable Stage III and Stage IV Melanoma | terminated | Phase 1 / Phase 2 | 2 | Prof. Dr. Silke GillessenOTHER | 1 | Sep 18, 2013 | clinicaltrials |
| NCT00025597 | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma. | completed | Phase 2 | — | European Infant Neuroblastoma Study Group - 1999OTHER | 11 | Sep 17, 2013 | clinicaltrials |
| NCT00025610 | Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma | completed | Phase 2 | — | European Infant Neuroblastoma Study Group - 1999OTHER | 11 | Sep 17, 2013 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials